For example: For all adults aged 60 and older, the societal cost per QALY saved was $196,842 for GSK's Arexvy and $176,557 for Pfizer's Abrysvo. For adults aged 65 and older, the cost was lower at ...

The National Democratic Congress has incurred the wrath of the Nkoranza Chiefs after standing them up According to the chiefs, they sat down from 9:00 am to 6:00 pm, waiting for the NDC and John ...

NAPO claimed that the NDC orchestrated the deaths of Prophet Asare, Brother Amoako, and Nana Drobo, a traditionalist renowned for inventing an HIV drug. He made these allegations during a speech ...

It plans to launch 12 new drugs by 2025, including successful new treatments like Arexvy and Ojjaara. The stock is currently trading at 9.2x forward earnings. Moreover, GSK stock offers a 3.85% ...

The CDC recommends a single dose of either GSK’s AREXVY, Moderna’s mRESVIA or Pfizer’s ABRYSVO for all adults 75 years and older and adults between the ages of 60 to 74 who are at increased ...

The European Commission (EC) has authorised GSK’s Arexvy for active immunisation against lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in adults aged 50 to ...

The CDC recommends a single dose of either GSK’s AREXVY, Moderna’s mRESVIA or Pfizer’s ABRYSVO for all adults 75 years and older and adults between the ages of 60 to 74 who are at increased risk of ...